‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers

Author: The Guardian

Date: 6/17/25

Language: English

Learn More: https://www.theguardian.com/society/2025/jun/17/hiv-ending-drug-lenacapavir-manufacture-cost-per-patient-gilead

You might also enjoy

Big Pharma is using tariffs to hold Europe to ransom

Pharma lobbyists cash in on Brussels red tape rampage

Big pharma is at war with the UK, and the government can’t back down now

All-Party ParliamentaryGroup on Pharmacy

World Health Organization Approves Rapid-Acting Insulin Analogues to the 24th EML

Romania vrea sa-si faca medicamentele acasa | Moment strategic pentru industria farmaceutica